Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia
Condition(s):Leukemia, MyeloidLast Updated:July 24, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Leukemia, MyeloidLast Updated:July 24, 2018Unknown status
Condition(s):Multiple SclerosisLast Updated:January 9, 2024Recruiting
Condition(s):Androgenic AlopeciaLast Updated:March 22, 2024Not yet recruiting
Condition(s):Ocular Surface DiseaseLast Updated:April 15, 2022Completed
Condition(s):Recessive Dystrophic Epidermolysis BullosaLast Updated:September 24, 2019Completed
Condition(s):Safety Issues;Effect of DrugsLast Updated:February 24, 2021Recruiting
Condition(s):Hematologic Malignancy; Large B-cell Lymphoma; Acute Lymphoblastic Leukemia; Mantle Cell Lymphoma; Multiple Myeloma; Diffuse Large B Cell LymphomaLast Updated:March 6, 2024Recruiting
Condition(s):Heart Failure; Heart Attack; Coronary Artery Bypass SurgeryLast Updated:December 2, 2015Completed
Condition(s):Autologous Hematopoietic Stem Cell Transplantation; Conditioning; Multiple MyelomaLast Updated:February 25, 2020Unknown status
Condition(s):DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:August 20, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.